Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical Outcomes.
Tan VS, Correa RJM, Nguyen TK, Louie AV, Malthaner RA, Fortin D, Rodrigues GB, Yaremko BP, Laba JM, Kwan K, Gaede S, Lee T, Ward AD, Warner A, Inculet RI, Palma DA. Tan VS, et al. Among authors: yaremko bp. Int J Radiat Oncol Biol Phys. 2025 Jan 1;121(1):39-44. doi: 10.1016/j.ijrobp.2024.07.2332. Epub 2024 Oct 1. Int J Radiat Oncol Biol Phys. 2025. PMID: 39362312 Free article. Clinical Trial.
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.
Swaminath A, Parpia S, Wierzbicki M, Kundapur V, Faria S, Okawara GS, Tsakiridis TK, Ahmed N, Bujold A, Hirmiz K, Owen T, Leong N, Ramchandar K, Filion E, Lau H, Gabos Z, Thompson R, Yaremko B, Mehiri S, Louie AV, Quan K, Levine MN, Wright JR, Whelan TJ. Swaminath A, et al. JAMA Oncol. 2024 Nov;10(11):1571-1575. doi: 10.1001/jamaoncol.2024.3089. Epub 2024 Sep 19. JAMA Oncol. 2024. PMID: 39298144 Free PMC article. Clinical Trial.
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
Whelan TJ, Julian JA, Berrang TS, Kim DH, Germain I, Nichol AM, Akra M, Lavertu S, Germain F, Fyles A, Trotter T, Perera FE, Balkwill S, Chafe S, McGowan T, Muanza T, Beckham WA, Chua BH, Gu CS, Levine MN, Olivotto IA; RAPID Trial Investigators. Whelan TJ, et al. Lancet. 2019 Dec 14;394(10215):2165-2172. doi: 10.1016/S0140-6736(19)32515-2. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813635 Clinical Trial.
Intensity-modulated radiotherapy in the treatment of gynaecological cancers.
D'Souza DP, Rumble RB, Fyles A, Yaremko B, Warde P; Members of the IMRT Indications Expert Panel. D'Souza DP, et al. Clin Oncol (R Coll Radiol). 2012 Sep;24(7):499-507. doi: 10.1016/j.clon.2012.05.005. Epub 2012 Jun 13. Clin Oncol (R Coll Radiol). 2012. PMID: 22703725 Review.
What is the predictive value of RECIST criteria following stereotactic lung radiation?
Gulstene S, Lang P, Melody Qu X, Laba JM, Yaremko BP, Rodrigues GB, Yu E, Qiabi M, Nayak R, Malthaner RA, Fortin D, Warner A, Inculet RI, Palma DA. Gulstene S, et al. Among authors: yaremko bp. Radiother Oncol. 2024 Jan;190:109976. doi: 10.1016/j.radonc.2023.109976. Epub 2023 Oct 31. Radiother Oncol. 2024. PMID: 37918636 Review.
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocol.
Kidane B, Gerard IJ, Spicer J, Kim JO, Fiset PO, Wawryko P, Cecchini MJ, Inculet R, Abdulkarim B, Fortin D, Qiabi M, Qing G, Enns S, Bashir B, Tankel J, Wakeam E, Warner A, Kopek N, Yaremko BP, Rodrigues GB, Laba JM, Qu M, Malthaner RA, Palma DA. Kidane B, et al. Among authors: yaremko bp. Cancer. 2023 Sep 15;129(18):2798-2807. doi: 10.1002/cncr.34880. Epub 2023 May 23. Cancer. 2023. PMID: 37221679 Free article.
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.
Yu E, Allan AL, Sanatani M, Lewis D, Warner A, Dar AR, Yaremko BP, Lowes LE, Palma DA, Raphael J, Vincent MD, Rodrigues GB, Fortin D, Inculet RI, Frechette E, Bierer J, Law J, Younus J, Malthaner RA. Yu E, et al. Among authors: yaremko bp. BMC Cancer. 2022 Jul 8;22(1):746. doi: 10.1186/s12885-022-09846-0. BMC Cancer. 2022. PMID: 35804307 Free PMC article. Clinical Trial.
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes.
Harrow S, Palma DA, Olson R, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP, Schellenberg D, Ahmad B, Senthi S, Swaminath A, Kopek N, Liu M, Schlijper R, Bauman GS, Laba J, Qu XM, Warner A, Senan S. Harrow S, et al. Among authors: yaremko bp. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):611-616. doi: 10.1016/j.ijrobp.2022.05.004. Epub 2022 May 26. Int J Radiat Oncol Biol Phys. 2022. PMID: 35643253 Clinical Trial.
The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial.
Malthaner RA, Yu E, Sanatani M, Lewis D, Warner A, Dar AR, Yaremko BP, Bierer J, Palma DA, Fortin D, Inculet RI, Fréchette E, Raphael J, Gaede S, Kuruvilla S, Younus J, Vincent MD, Rodrigues GB. Malthaner RA, et al. Among authors: yaremko bp. Thorac Cancer. 2022 Jul;13(13):1898-1915. doi: 10.1111/1759-7714.14433. Epub 2022 May 24. Thorac Cancer. 2022. PMID: 35611396 Free PMC article. Clinical Trial.
Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled Trial.
Yaremko BP, Capaldi DPI, Sheikh K, Palma DA, Warner A, Dar AR, Yu E, Rodrigues GB, Louie AV, Landis M, Sanatani M, Vincent MD, Younus J, Kuruvilla S, Chen JZ, Erickson A, Gaede S, Parraga G, Hoover DA. Yaremko BP, et al. Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1072-1084. doi: 10.1016/j.ijrobp.2022.04.047. Epub 2022 May 9. Int J Radiat Oncol Biol Phys. 2022. PMID: 35550405 Clinical Trial.
37 results